Published in Circulation on October 23, 2001
Collateral circulation: past and present. Basic Res Cardiol (2008) 2.60
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol (2005) 1.58
Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med (2008) 1.38
Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol (2010) 1.17
Therapeutic myocardial angiogenesis. Microvasc Res (2007) 1.16
Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications. Microcirculation (2010) 1.15
Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci U S A (2007) 1.09
The human coronary collateral circulation. Heart (2003) 1.08
Adult bone-marrow stem cells and their potential in medicine. J R Soc Med (2004) 1.06
Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch (2006) 1.05
Vascular growth in health and disease. Front Mol Neurosci (2011) 0.94
Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond. Basic Res Cardiol (2011) 0.91
The future of collateral artery research. Curr Cardiol Rev (2014) 0.86
Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke. Proc Natl Acad Sci U S A (2004) 0.85
Transplantation of bone marrow derived monocytes: a novel approach for augmentation of arteriogenesis in a murine model of femoral artery ligation. Am J Transl Res (2013) 0.83
The collateral circulation of the heart. BMC Med (2013) 0.83
Mesenchymal stem cells for treatment of myocardial infarction. Int J Stem Cells (2008) 0.83
Local granulocyte-macrophage colony-stimulating factor improves incisional wound healing in adriamycin-treated rats. Surg Today (2006) 0.82
Endothelial glycocalyx dimensions are reduced in growing collateral arteries and modulate leucocyte adhesion in arteriogenesis. J Cell Mol Med (2009) 0.82
Therapeutic arteriogenesis has arrived. Circulation (2001) 0.80
Recent insights into human coronary collateral development. Heart (2004) 0.80
Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy. Heart Fail Rev (2007) 0.80
Blood vessel repair and regeneration in the ischaemic heart. Open Heart (2014) 0.79
SHIPi Enhances Autologous and Allogeneic Hematolymphoid Stem Cell Transplantation. EBioMedicine (2015) 0.78
Cellular and pharmacological targets to induce coronary arteriogenesis. Curr Cardiol Rev (2014) 0.77
Coronary collateral flow and peripheral blood monocyte concentration in patients treated with granulocyte-macrophage colony stimulating factor. Heart (2004) 0.76
Locally applied molgramostim improves wound healing at colonic anastomoses in rats after ligation of the common bile duct. Can J Surg (2005) 0.76
Therapeutic approaches in the stimulation of the coronary collateral circulation. Curr Cardiol Rev (2014) 0.75
Effect of granulocyte colony stimulating EPC on cardiac function and myocardial energy expenditure in patients with heart failure after myocardial infarction. Int J Clin Exp Med (2015) 0.75
Which Coronary Lesions Are More Prone to Cause Acute Myocardial Infarction? Arq Bras Cardiol (2017) 0.75
Novel molecular targets for coronary angiogenesis and ischemic heart disease. Coron Artery Dis (2017) 0.75
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med (1992) 5.32
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med (2001) 5.09
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol (2000) 4.96
Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation (2000) 3.75
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021. Proc Natl Acad Sci U S A (2001) 2.83
Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol (1999) 2.70
Conservation of microstructure between a sequenced region of the genome of rice and multiple segments of the genome of Arabidopsis thaliana. Genome Res (2001) 2.56
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart (2007) 2.40
Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene (1999) 2.27
Huntington disease-linked locus D4S111 exposed as the alpha-L-iduronidase gene. Somat Cell Mol Genet (1991) 2.23
Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22
Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol (1992) 2.19
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today (1993) 2.09
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology (2004) 2.09
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet (1978) 2.00
Molecular approaches to mammalian genetics. Cold Spring Harb Symp Quant Biol (1986) 1.99
Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation (1986) 1.99
Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg (2000) 1.94
Diastolic heart failure. Cardiovasc Res (2000) 1.92
A novel nuclear pore protein Nup82p which specifically binds to a fraction of Nsp1p. J Cell Biol (1995) 1.90
Regional expression of the homeobox gene Nkx-2.2 in the developing mammalian forebrain. Neuron (1992) 1.85
Patent foramen ovale and neurosurgery in sitting position: a systematic review. Br J Anaesth (2009) 1.82
Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation (1997) 1.76
Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol (1998) 1.70
HDF2, the second subunit of the Ku homologue from Saccharomyces cerevisiae. J Biol Chem (1996) 1.68
Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol (2001) 1.68
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation (1999) 1.66
Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry (2002) 1.63
Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn (1995) 1.62
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart (2005) 1.61
Retracted Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J (1999) 1.60
Stenting of superior vena cava and inferior vena cava for symptomatic narrowing after repeated atrial surgery for D-transposition of the great vessels. Br Heart J (1991) 1.59
A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc (2000) 1.58
Prevention of stroke in patients with patent foramen ovale. Int J Stroke (2010) 1.57
Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol Rev (2000) 1.51
Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization. Eur Heart J (2000) 1.49
Aortic dissection as complication of percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn (1992) 1.48
Indications for intracoronary stent placement: the european view. Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.46
The complete DNA sequence of the Ectocarpus siliculosus Virus EsV-1 genome. Virology (2001) 1.46
Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol (2001) 1.46
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Impossibility to cross a stenotic mitral valve with the Inoue balloon: success with a modified technique. Indian Heart J (1994) 1.44
Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol (2000) 1.43
Coronary artery spasm and non-Q-wave myocardial infarction following intravenous ephedrine in two healthy women under spinal anaesthesia. Br J Anaesth (2002) 1.43
The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes. Cardiology (2007) 1.40
Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach. Circulation (1983) 1.40
Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study. J Hypertens (2001) 1.40
Left main coronary angioplasty in a 10-year-old boy with homozygous familial hypercholesterolemia. Cathet Cardiovasc Diagn (1993) 1.40
Coronary interventions in Europe 1992. The Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1995) 1.39
[Cardiac interventions in Switzerland 1992. PTCA and Fibrinolysis Work Group of the Swiss Cardiology Association]. Schweiz Med Wochenschr (1994) 1.39
[Treatment of fallopian tube pregnancies with prostaglandins]. Geburtshilfe Frauenheilkd (1991) 1.38
Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial. Am Heart J (1998) 1.38
[Coronary angioplasty without surgical standby: a prospective study]. G Ital Cardiol (1992) 1.37
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically. J Biol Chem (2001) 1.27
Ultrasound-guided compression repair for treatment of femoral artery pseudoaneurysm: acute and follow-up results. Cathet Cardiovasc Diagn (1996) 1.27
Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol (2000) 1.26
Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol (1997) 1.24
Balloon angioplasty for acute myocardial infarction. Was it buried alive? Circulation (1990) 1.24
Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology (2005) 1.24
Molecular cloning and partial nucleotide sequence of human papillomavirus type 1a DNA. Virology (1982) 1.22
Concentration of proteins and removal of solutes. Methods Enzymol (1990) 1.22
Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B. J Biol Chem (1995) 1.21
Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? Circulation (1983) 1.21
Retracted The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol (2001) 1.20
Nature of T-cell macrophage interaction in helper-cell induction in vitro. II. Two stages of T-helper-cell differentiation analyzed in irradiation and allophenic chimeras. J Exp Med (1979) 1.20
Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res (1997) 1.19
The Bacillus subtilis pnbA gene encoding p-nitrobenzyl esterase: cloning, sequence and high-level expression in Escherichia coli. Gene (1994) 1.18
Synthesis of either Fe- or Mn-superoxide dismutase with an apparently identical protein moiety by an anaerobic bacterium dependent on the metal supplied. J Biol Chem (1982) 1.16
Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. Am J Cardiol (1987) 1.15
Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplasty. J Am Coll Cardiol (1987) 1.14
Risk of side branch occlusion during coronary angioplasty. Am J Cardiol (1984) 1.13
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother (1987) 1.11
Sleep need in adolescents: a longitudinal approach. Sleep (1988) 1.11
Kissing balloon coronary angioplasty. Am J Cardiol (1984) 1.10
Nature of T cell-macrophage interaction in helper cell induction in vitro. I. Evidence for genetic restriction of T cell-macrophage interactions prior to T cell priming. Eur J Immunol (1978) 1.10
Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res (2005) 1.08
ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation (2000) 1.08